The Radcliffe Cardiology Podcast The Radcliffe Cardiology Podcast

In this episode, Prof Juan Pablo Kaski is joined by Dr Jodie Ingles and Dr Elena Biagini to discuss long-term management, expectations in cardiology, community care and family genetic screening. Tune in for expert insights on supporting patients and their families.

What's hot at EuroPCR 2024?

Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC's Thoraxcenter for an insightful preview of the late-breaking science data to look out for at the 2024 EuroPCR meeting.

What is the potential impact of the new data on practice? What details should we look out for? What is the context of the EuroPCR trials?

Trials covered included:
00:46 - CAREER
02:03 - Angiography-based Radial Wall Strain in Predicting Non-Culprit Vessel Failure
04:05 - DOCTORS-LM
07:41 - TCW
09:35 - SOLVE-TAVI
12:27 - NOTION-2
14:41 - LANDMARK
16:36 - AltaValve
17:53 - LuxValvePlus
19:12 - CALIPSO
21:44 - ROTA-ISR
23:57 - ROLLERCOASTR
25:20 - Balloon Angioplasty Vs Shockwave Intravascular Lithotripsy
25:29 - OCT Vs IVUS

In the first episode, Prof Juan Pablo Kaski and Prof Ruxandra Jurcut discuss the essentials of establishing an HCM Clinic, covering its objectives, logistical aspects, systemic challenges, and operational strategies, including referral practices and collaboration with specialist centres.

Unpack ACC.24's Top Trials with View from the Thoraxcenter!

Join Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC, Rotterdam for a deep dive into the late-breaking data presented at ACC.24.

In this thought-provoking ACC 2024 wrap-up, delve into the nuances of the most impactful trials, gaining insights into their implications for current practice and future research directions.

00:29 - Ultimate DAPT
02:49 - IVUS-ACS
04:22 - RELIEVE-HF
08:00 - ORBITA-COSMIC
11:12 - EMPACT-MI
14:36 - REDUCE-AMI
17:51 - DEDICATE-DZHK6
22:32 - SMART
26:26 - PREVENT
29:08 - FULL REVASC
33:43 - DanGer Shock
39:44 - TARGET BP I

In this episode of the Radcliffe Podcast, we are joined by Dr Raymond Pranata, Dr Mohammad Iqbal and Dr Giky Karwiky (Hasan Sadikin General Hospital, Bandung, Indonesia) as they discuss their recently published systematic review and meta-analysis of very-high-power short-duration ablation as compared to conventional ablation for the treatment of pulmonary vein isolation in atrial fibrillation.

13 studies were included in their analysis, which found that VHPSD ablation was associated with lower AF recurrence as compared to the conventional ablation group. Subgroup analysis showed that additional ablation beyond PVI had a similar rate of AF recurrence compared to PVI alone.

If you have any questions or suggestions, please email managingeditor@ecrjournal.com.

What's hot at #AHA23?

Join Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) as they review the latest late-breaking science data from AHA Scientific Sessions 2023.

They interpret the evidence from five key trials, providing context, asking thought-provoking questions to translate the data into key take-home messages for practice and research.

Trials Covered include:
00:20 - DAPA-MI: Dapagliflozin Effects on Cardiometabolic Outcomes in Patients With an Acute Heart Attack

06:30 - ORBITA-2: Percutaneous Coronary Intervention for Stable Angina: A Randomised, Placebo-Controlled Trial

12:39 - A Sub-Analysis of the Prospective ECLS-Shock Trial

16:13 - ARTESiA: Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation

10:02 - SELECT: Semaglutide and Cardiovascular Outcomes in Patients With Overweight or Obesity Who Do Not Have Diabetes

We value your opinion! Share your feedback by commenting on this page or sending us an email at info@radcliffe-group.com.